TIAA CREF Investment Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $513K | Buy |
25,793
+207
| +0.8% | +$4.12K | ﹤0.01% | 2590 |
|
|
2018
Q4 | $338K | Sell |
25,586
-18,350
| -42% | -$242K | ﹤0.01% | 2732 |
|
|
2018
Q3 | $1.62M | Sell |
43,936
-23,946
| -35% | -$880K | ﹤0.01% | 2229 |
|
|
2018
Q2 | $2.38M | Buy |
67,882
+34,199
| +102% | +$1.2M | ﹤0.01% | 2076 |
|
|
2018
Q1 | $1.57M | Buy |
33,683
+8,368
| +33% | +$389K | ﹤0.01% | 2234 |
|
|
2017
Q4 | $949K | Buy |
25,315
+3,847
| +18% | +$144K | ﹤0.01% | 2493 |
|
|
2017
Q3 | $1.14M | Buy |
21,468
+237
| +1% | +$12.6K | ﹤0.01% | 2456 |
|
|
2017
Q2 | $1.21M | Buy |
21,231
+1,542
| +8% | +$87.9K | ﹤0.01% | 2460 |
|
|
2017
Q1 | $1.06M | Sell |
19,689
-752
| -4% | -$40.4K | ﹤0.01% | 2483 |
|
|
2016
Q4 | $1.17M | Sell |
20,441
-9,004
| -31% | -$513K | ﹤0.01% | 2450 |
|
|
2016
Q3 | $1.83K | Buy |
29,445
+4,308
| +17% | +$268 | ﹤0.01% | 2229 |
|
|
2016
Q2 | $1.42M | Buy |
25,137
+19,623
| +356% | +$1.11M | ﹤0.01% | 2331 |
|
|
2016
Q1 | $353K | Sell |
5,514
-4,698
| -46% | -$301K | ﹤0.01% | 2881 |
|
|
2015
Q4 | $1.44M | Buy |
10,212
+4,698
| +85% | +$661K | ﹤0.01% | 2356 |
|
|
2015
Q3 | $534K | Buy |
5,514
+3,282
| +147% | +$318K | ﹤0.01% | 2867 |
|
|
2015
Q2 | $338K | Buy |
+2,232
| New | +$338K | ﹤0.01% | 3046 |
|